Simplex Trading’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.7K | Sell |
800
-41,800
| -98% | -$439K | ﹤0.01% | 7690 |
|
|
2025
Q4 | $613K | Sell |
42,600
-10,700
| -20% | -$133K | ﹤0.01% | 3097 |
|
|
2025
Q3 | $514K | Buy |
53,300
+40,700
| +323% | +$360K | ﹤0.01% | 3795 |
|
|
2025
Q2 | $103K | Buy |
12,600
+7,600
| +152% | +$63.6K | ﹤0.01% | 5210 |
|
|
2025
Q1 | $35K | Buy |
5,000
+2,600
| +108% | +$19.3K | ﹤0.01% | 6118 |
|
|
2024
Q4 | $18K | Sell |
2,400
-600
| -20% | -$5.63K | ﹤0.01% | 6774 |
|
|
2024
Q3 | $31K | Sell |
3,000
-5,700
| -66% | -$69.5K | ﹤0.01% | 6335 |
|
|
2024
Q2 | $101K | Buy |
8,700
+2,500
| +40% | +$38.9K | ﹤0.01% | 5363 |
|
|
2024
Q1 | $130K | Buy |
6,200
+2,300
| +59% | +$40.9K | ﹤0.01% | 5316 |
|
|
2023
Q4 | $70K | Buy |
3,900
+1,400
| +56% | +$24.7K | ﹤0.01% | 5753 |
|
|
2023
Q3 | $41K | Sell |
2,500
-2,800
| -53% | -$50.7K | ﹤0.01% | 5985 |
|
|
2023
Q2 | $105K | Buy |
5,300
+900
| +20% | +$17.3K | ﹤0.01% | 5029 |
|
|
2023
Q1 | $83K | Buy |
4,400
+2,000
| +83% | +$44.3K | ﹤0.01% | 5363 |
|
|
2022
Q4 | $54K | Sell |
2,400
-4,200
| -64% | -$94.9K | ﹤0.01% | 5792 |
|
|
2022
Q3 | $174K | Buy |
+6,600
| New | +$196K | ﹤0.01% | 4789 |
|
|
2022
Q2 | – | Sell |
-200
| Closed | -$6K | – | 10899 |
|
|
2022
Q1 | $6K | Buy |
200
+100
| +100% | +$2.78K | ﹤0.01% | 9317 |
|
|
2021
Q4 | $3K | Sell |
100
-700
| -88% | -$23.8K | ﹤0.01% | 9856 |
|
|
2021
Q3 | $31K | Hold |
800
| – | – | ﹤0.01% | 8066 |
|
|
2021
Q2 | $31K | Buy |
800
+795
| +15,900% | +$28.4K | ﹤0.01% | 8205 |
|
|
2021
Q1 | $17K | Sell |
5
-4
| -44% | -$171 | ﹤0.01% | 7590 |
|
|
2020
Q4 | $40K | Sell |
9
-5
| -36% | -$175 | ﹤0.01% | 6407 |
|
|
2020
Q3 | $38K | Sell |
14
-289
| -95% | -$9.42K | ﹤0.01% | 5877 |
|
|
2020
Q2 | $1.11M | Buy |
303
+7
| +2% | +$261 | ﹤0.01% | 2048 |
|
|
2020
Q1 | $958K | Buy |
296
+5
| +2% | +$208 | ﹤0.01% | 1927 |
|
|
2019
Q4 | $1.19M | Buy |
291
+255
| +708% | +$10.1K | ﹤0.01% | 1931 |
|
|
2019
Q3 | $128K | Sell |
36
-154
| -81% | -$6.24K | ﹤0.01% | 4054 |
|
|
2019
Q2 | $976K | Sell |
190
-256
| -57% | -$12.8K | ﹤0.01% | 1929 |
|
|
2019
Q1 | $2.56M | Buy |
446
+439
| +6,271% | +$21.7K | 0.01% | 1155 |
|
|
2018
Q4 | $29K | Sell |
7
-61
| -90% | -$3.58K | ﹤0.01% | 5029 |
|
|
2018
Q3 | $513K | Buy |
68
+12
| +21% | +$865 | ﹤0.01% | 2604 |
|
|
2018
Q2 | $401K | Buy |
56
+13
| +30% | +$621 | ﹤0.01% | 2687 |
|
|
2018
Q1 | $7K | Buy |
+43
| New | +$1.25K | ﹤0.01% | 4361 |
|
Other funds holding RGNX
RG
VCM
IHAM
Simplex Trading's RGNX Position: Q1 2026 in Review
Simplex Trading sold out of Regenxbio (RGNX) in Q1 2026, closing a stake of 6,234 shares — an estimated $65.5K sold.
Simplex Trading first reported a position in RGNX in Q4 2017 and held it in 22 quarters. The position peaked at $2.12M in Q4 2020. 178 funds tracked by Wall St. Rank hold RGNX as of Q1 2026.
- Simplex Trading reported no remaining Regenxbio position as of Q1 2026 after selling out during the quarter.
- Simplex Trading sold 6,234 Regenxbio shares in Q1 2026, an estimated $65.5K.
- Simplex Trading first reported a position in Regenxbio in Q4 2017 and held it in 22 quarters.
- Simplex Trading's Regenxbio position peaked at $2.12M in Q4 2020.
- 178 funds tracked by Wall St. Rank held Regenxbio as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.